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Abstract The human major histocompatibility complex
(MHC) is contained within about 4 Mb on the short arm of
chromosome 6 and is recognised as the most variable
region in the human genome. The primary aim of the MHC
Haplotype Project was to provide a comprehensively
annotated reference sequence of a single, human leukocyte
antigen-homozygous MHC haplotype and to use it as a
basis against which variations could be assessed from seven
other similarly homozygous cell lines, representative of the
most common MHC haplotypes in the European popula-
tion. Comparison of the haplotype sequences, including
four haplotypes not previously analysed, resulted in the
identification of >44,000 variations, both substitutions and
indels (insertions and deletions), which have been submit-
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Cambridge CB2 0XY, UKted to the dbSNP database. The gene annotation uncovered
haplotype-specific differences and confirmed the presence
of more than 300 loci, including over 160 protein-coding
genes. Combined analysis of the variation and annotation
datasets revealed 122 gene loci with coding substitutions of
which 97 were non-synonymous. The haplotype (A3-B7-
DR15; PGF cell line) designated as the new MHC reference
sequence, has been incorporated into the human genome
assembly (NCBI35 and subsequent builds), and constitutes
the largest single-haplotype sequence of the human genome
to date. The extensive variation and annotation data derived
from the analysis of seven further haplotypes have been
made publicly available and provide a framework and
resource for future association studies of all MHC-associ-
ated diseases and transplant medicine.
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Introduction
The MHC has long been believed to be the most important
region in the human genome with respect to infection,
inflammation, autoimmunity and transplant medicine
(Lechler and Warrens 2000). This was recently confirmed
by the largest genome-wide association study carried out to
date for seven common diseases, including two autoim-
mune diseases (type 1 diabetes and rheumatoid arthritis)
and one inflammatory disease (Crohn’s disease). The
highest associations were found between the MHC and
these two autoimmune diseases (The Wellcome Trust Case
Control Consortium 2007). The complex aetiology of
MHC-associated disease coupled with high density, poly-
morphism, linkage disequilibrium (LD) and frequent non-
Mendelian inheritance of gene loci have made it challenging
to identify variations that cause or contribute to disease
phenotypes. Additional limiting factors have been our
incomplete knowledge of the allelic variation of genes and
regions flanking the nine classical human leukocyte antigen
(HLA) loci and the lack of a single haplotype reference
sequence, the original reference sequence being a composite
of multiple MHC haplotypes (Mungall et al. 2003;T h e
MHC Sequencing Consortium 1999).
Recognizing that the future identification of variants
conferring susceptibility to common disease is critically
dependent on fully informative polymorphism and haplo-
type maps, the MHC Haplotype Consortium formed in
2000 with the aim to generate these critical data and to
make them publicly available as a general resource for
MHC-linked disease studies. Similar efforts, but with
different experimental approaches, were also carried out in
Japan (Shiina et al. 2006) and the USA (Smith et al. 2006).
To develop the resource, eight HLA-homozygous MHC
haplotypes were selected on the basis of conferring either
protection against or susceptibility to two autoimmune
diseases, type 1 diabetes and multiple sclerosis, and that
represented common haplotypes in European populations.
In the subsequent years, incremental data, materials
and tools comprising this resource have been released
(Allcock et al. 2002; Horton et al. 2004; Stewart et al. 2004;
Traherne et al. 2006) and have contributed towards the
construction of a high-resolution LD map and a first
generation of HLA tag single nucleotide polymorphisms
(SNPs; de Bakker et al. 2006; Miretti et al. 2005) and the
identification of a second MHC susceptibility locus for
multiple sclerosis (The International Multiple Sclerosis
Genetics Consortium; Yeo et al. 2007). In this paper, we
report the final account of this international effort, including,
analysis of the last four of the eight haplotypes, up-to-date
variation statistics, gene annotation, population-specific
aspects and a detailed description of the databases and tools
for viewing and accessing the data in the context of existing
genome annotation.
Materials and methods
Variation analysis
The method previously reported for comparison of MHC
haplotype sequences (Stewart et al. 2004; Traherne et al.
2006) was extended to cover all eight haplotypes. Briefly,
the most suitable method proved to be a clone by clone
comparison using the discrepancy-list option of the cross_
match program (Green, unpublished; http://www.phrap.org/),
an implementation of the Smith–Waterman sequence align-
ment algorithm (Smith and Waterman 1981), using the
alignment of a haplotype clone sequence with the appropriate
overlapping reference sequence from a PGF clone or clones.
All variations were submitted to dbSNP using the submitter
handle SI_MHC_SNP and user identifiers of the form [PGF
BAC clone sequence version]_[position in PGF BAC clone
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indicates a substitution in which the base T at base position
6645 in AL662890.3 (PGF BAC 308K3) was substituted by
C in the other haplotype. In the case of indels, the ‘variation
change’ consists of ‘i’ or ‘d’ (for insertion or deletion),
followed by a numerical value for the length of the indel, in
turn followed by the inserted or deleted sequence if this were
of 12 or fewer bases. For longer indels, an X value is given,
which refers to a look-up table (http://www.sanger.ac.uk/HGP/
Chr6/MHC/Xfile). Thus, AL662890.3_7470_d8TACACACA
indicates a deletion in AL662890.3 after base 7470 of the
eight bases ‘TACACACA’. Further, AL662890.3_10559_i5A-
TATT indicates an insertion in AL662890.3 starting after base
10559 of the five bases ‘ATATT’. AL662890.3_7475_ d14X1
indicates a 14-base deletion after base 7475 in AL662890.3 of
a sequence coded as X1 which is ‘ATACACACACACAC’.
Major indel sequences, appearing as breaks in the
cross_match discrepancy lists between two clones from
difference haplotypes, were extracted and subjected to
analysis by RepeatMasker to detect the presence of
retrotransposible elements.
Gene annotation
The finished genomic sequence for each of the eight
haplotypes was analysed using a modified Ensembl
pipeline (Searle et al. 2004). CpG islands were predicted
on unmasked sequence. Interspersed and tandem repeats
were masked out by RepeatMasker (Smit, AFA, Hubley, R
& Green, P. RepeatMasker Open-3.0. 1996–2004, http://
www.repeatmasker.org) and Tandem Repeats Finder (TRF;
Benson 1999), respectively. The sequence was then BLAST
searched (BLAST, basic local alignment search tool;
Altschul et al. 1990) using a vertebrate set of complemen-
tary DNAs (cDNAs) and expressed sequence tags (ESTs)
from the European Molecular Biology Laboratory (EMBL)
nucleotide database (Kulikova et al. 2007), followed by the
re-alignment of significant hits. Non-redundant proteins
were aligned similarly. Protein domain matches were
provided through alignment of Pfam to the genomic
sequence using Genewise (Birney et al. 2004), thereby
providing protein domain data to the annotator. Ab initio
gene predictions were performed by Genscan (Burge and
Karlin 1997) and Fgenesh (Salamov and Solovyev 2000),
and potential transcriptional start sites were predicted by
Eponine (Down and Hubbard 2002). Analysis results
were displayed, and annotation was performed through an
in-house annotation software system.
Genes were manually annotated according to the human
and vertebrate analysis and annotation (HAVANA) guide-
lines (http://www.sanger.ac.uk/HGP/havana/) using evidence
based on comparison with external databases as of August
2005. All gene structures are supported by transcriptional
evidence, either from cDNA, EST, or protein. In general,
annotations are supported by best-in-genome evidence.
Haplotype-specific evidence is assigned where possible. As
with previous MHC annotation (Stewart et al. 2004;
Traherne et al. 2006), some olfactory receptors have been
built upon protein homology alone because of their restricted
expression.
Locus and variant types were annotated according to
established standards (Harrow et al. 2006), with the
modification that, within the MHC region, the artefact
locus has been used to tag historically annotated structures
that are no longer deemed valid.
HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, and
HLA-DQB1 allele types were assessed by comparison
against the IMGT/HLA database (http://www.ebi.ac.uk/
imgt/hla/; Marsh et al. 2005).
Annotation status of haplotypes
The PGF, COX, and QBL haplotypes have already been
annotated in detail (Stewart et al. 2004; Traherne et al.
2006). It was decided, however, to re-annotate and update
this annotation to maintain consistency between all eight
haplotypes with the current supporting evidence and
pipeline analyses. The SSTO haplotype was manually
annotated de novo. The new annotation from the PGF
haplotype was projected through a DNA–DNA alignment
to each of the remaining haplotypes (APD, DBB, MANN
and MCF) where possible. This projection was checked
thoroughly and non-alignable regions were manually
adjusted (including the C4 and HLA-DRB1 hypervariable
regions). Polyadenylation sites and signals were not
annotated for haplotypes APD, DBB, MANN and MCF
because of time constraints. In the main, however, these
features may be assumed to correspond to the same
positions as in the first four haplotypes.
Combination of variation and annotation data
By employing a series of Perl scripts, the array of haplotype
variation was combined with the annotation of gene loci,
repeat elements and microsatellites, extracted from the
Vertebrate Genome Annotation (VEGA) database in general
feature format (GFF; http://www.sanger.ac.uk/Software/for-
mats/GFF/), to determine the variation status of all loci.
Distribution of sequenced HLA haplotypes in Europeans
To assess the distribution of sequenced haplotypes at the
population level, 180 founder haplotypes were recon-
structed using genotypic data from Centre d’Etude Poly-
morphisme Humain (CEPH) trios (de Bakker et al. 2006).
A ~214 kb segment spanning the HLA–DRB1–DQB1 genes
Immunogenetics (2008) 60:1–18 3was selected for the analyses. This segment, represented by
54 SNPs, is delimited by rs2187823 and rs2856691, with
NCBI build 36 chromosome 6 coordinates 32547486 and
32761413, respectively. Phased haplotypes with known
HLA–DRB1–DQB1 alleles were then used to construct a
neighbor-joining tree (Kumar et al. 2001) and a phyloge-
netic network (Bandelt et al. 1999).
Resources
All sequences presented in this paper have been submitted
to the EMBL/GenBank/DNA Data Bank of Japan (DDBJ)
database and allocated accession numbers. For clarity, all
bacterial artificial chromosome (BAC) clones are referred
to using their accession numbers. The annotation of each
haplotype has been entered in the VEGA database and is
accessible through its browser (http://www.VEGA.sanger.
ac.uk). All variations from the study were submitted to
dbSNP (http://www.ncbi.nlm.nih.gov/SNP)u s i n gt h e
submitter handle SI_MHC_SNP.
BAC clones from the CHORI-501 (PGF) and CHORI-502
(COX) libraries can be requested from BACPAC resources
(http://www.bacpac.chori.org/). Clones from the other libraries
can be requested from john.elliott@ualberta.ca.
The web site for the MHC Haplotype Project provides
links to various data resources (http://www.sanger.ac.uk/
HGP/Chr6/MHC/).
DAS sources for all substitutions and indels are available
from http://www.das.ensembl.org/das as follows:
– ens_35_COX_SNP ens_35_COX_DIP
– ens_35_QBL_SNP ens_35_QBL_DIP
– ens_35_SSTO_SNP ens_35_SSTO_DIP
– ens_35_APD_SNP ens_35_APD_DIP
– ens_35_DBB_SNP ens_35_DBB_DIP
– ens_35_MANN_SNP ens_35_MANN_DIP
– ens_35_MCF_SNP ens_35_MCF_DIP
These can be accessed via the VEGA browser.
Results and discussion
Variation analysis
One of the main aims of the MHC Haplotype Project was to
generate a comprehensive variation map of this most
variable region of the human genome. To achieve this,
eight haplotypes were sequenced and subjected to variation
analysis. Table 1 details the lengths of the sequence contigs,
the number of sequence gaps and the allelic types of major
HLA loci for each haplotype. Of the eight haplotypes
sequenced, three have already been described: PGF and
Cox (Stewart et al. 2004) both of which formed single
contigs of approximately 4.7 Mb, and QBL (Traherne et al.
2006), of approximately 4.2 Mb but with five gaps. The
remaining haplotypes sequenced all contained gaps, their
coverage ranging from 2.33 Mb (DBB with 28 gaps) to
4.19 Mb (MANN with 10 gaps).
For the variation analysis, each of the above haplotypes
was compared with the PGF reference sequence, resulting
in the identification of 44,544 variations (37,451 substitu-
tions and 7,093 indels, Table 2), which have all been
submitted to dbSNP. The success of this exercise is
illustrated by the fact that examination of this public
Table 1 Haplotype sequence contig length, number of gaps and HLA allele types
Haplotype Length (bp) Gaps HLA-A HLA-B HLA-C HLA-DQA1 HLA-DQB1 HLA-DRB1
PGF 4754829 0 A*03010101 B*070201 Cw*07020103 DQA1*010201 DQB1*0602 DRB1*150101
COX 4731878 0 A*01010101 B*080101 Cw*070101 DQA1*050101 DQB1*020101 DRB1*030101
QBL 4249272 5 A*260101 B*180101 Cw*050101 DQA1*050101 DQB1*020101 DRB1*030101
APD 4160965 16 A*01010101 –– – – −
DBB 2330101 28 A*02010101 – Cw*06020101 DQA1*0201 DQB1*030302 DRB1*070101
MANN 4191014 10 A*290201 B*440301 Cw*160101 DQA1*0201 DQB1*0202 DRB1*070101
MCF 4087413 15 [A*020101] B*15010101 Cw*030401 DQA1*0303 DQB1*030101 –
SSTO 3704249 22 A*320101 B*44020101 Cw*050101 DQA1*030101 DQB1*030501 DRB1*040301
Sequence length (bp) and number of gaps in each haplotype sequence, together with the HLA gene types obtained by BLAST against the IMGT/
HLA database. Dashes or data in square brackets indicate the absence or the partial presence, respectively, of a gene owing to a sequence gap
Table 2 Distribution of substitutions and indels amongst haplotypes
Haplotype Substitutions Indels ALL
COX 15,967 2,393 18,360
QBL 15,282 2,360 17,642
SSTO 14,982 2,300 17,282
APD 4,230 683 4,913
DBB 14,255 1,975 16,230
MANN 12,102 1,654 13,756
MCF 10,790 1,545 12,335
Overall 37,451 7,093 44,544
Number of variations found by comparing the PGF haplotype
sequence with each of the other haplotype sequences in turn
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Immunogenetics (2008) 60:1–18 5database (NCBI dbSNP build 127, March 2007) showed
that there were only a further 19,598 variations, submitted
by other laboratories, in this region which were not
identified by this project. In accordance with the annotation
that we also generated for each haplotype (see below), the
variations shown in Table 2 were further classified as
untranslated region (UTR), exonic, intronic, intergenic and
eight more sub-categories (Table 3). Coding substitutions,
which are of particular interest with respect to altered
functionality, were further classified as synonymous, non-
synonymous conservative, or non-synonymous non-
conservative and grouped depending on whether they
affected HLA or other genes (Table 4). The actual variations
and affected amino acids can be viewed using the VEGA
browser as illustrated in Fig. 1 and described in the
corresponding section later on. In addition, we have analysed
all haplotype sequences for inversions, which represent
another important variation category that has been linked to
genomic disorders (Shaw and Lupski 2004). Using Ssaha2
(Ning et al. 2001), we found no evidence of any inversion
polymorphism within the generated sequences but could not
exclude large-scale (e.g. involving entire MHC) inversions
with breakpoints outside the MHC regions sequenced here.
Gene annotation
There have been several previous annotations of the gene
content of the MHC (Horton et al. 2004; Mungall et al.
2003; Stewart et al. 2004; The MHC Sequencing Consor-
tium 1999; Traherne et al. 2006). The maximum region
annotated in this study extends from the telomeric ZNF452
gene in the MHC extended class I region (COX haplotype)
to the centromeric ZBTB9 gene just telomeric of the MHC
extended class II region (PGF and SSTO haplotypes). The
PGF haplotype (Stewart et al. 2004) remains the longest
complete MHC haplotype, encompassing 320 annotated
loci with 1,267 variants. The number of variants ascribed to
each locus-type is listed in Table 5. A comparison of the
statistics for loci in each haplotype is shown in Table 6.
VEGA database and browser
The VEGA database provides access to gene annotation of
the eight MHC haplotype sequences, a valuable public
resource and a means of integrating annotation and
variation data. The VEGA database also provides the
facility to download nucleotide or peptide sequences for
genes of interest, by selecting ‘export cDNA’ or ‘export
peptide’ from the menu obtained by clicking on gene
cartoons in the VEGA ‘detailed view’ or ‘basepair view’
window. From these, any desired alignments can be made.
Variation data may be viewed in the browser linked to a
distributed annotation system (DAS) source of any given
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6 Immunogenetics (2008) 60:1–18variation (see “Materials and methods”). This is illustrated
An example of the use of this browser to view a C to T
substitution is illustrated for the OR2J1 locus (Fig. 1). An
overview of the genomic environment is given in Fig. 1a,
showing the gene within a cluster of olfactory gene loci on
chromosome 6. The detailed view (Fig. 1b) shows OR2J1
with associated variations in all haplotypes. The basepair
view (Fig. 1c) illustrates the presence of the C/T substitu-
tion in all haplotypes except MCF, and its positioning
above the translated sequence, at the first position of a CAG
codon, indicating the presence of a stop codon instead of
glutamine.
Annotation changes
In addition to loci annotated in the previous studies, newly
recognised with official Hugo Gene Nomenclature Com-
mittee (HGNC) symbols have also been annotated. These
Fig. 1 Annotation and variation
data in VEGA. VEGA ‘over-
view’ (a), ‘detailed view’ (b)
and ‘basepair view’ (c) example
of the variation in the OR2J1
locus in which a STOP codon is
present in all haplotypes
except MCF
Immunogenetics (2008) 60:1–18 7have included the mitochondrial coiled–coil domain protein
1 gene MCCD1 (Semple et al. 2003) and the related
unprocessed pseudogenes MCCD1P1 and MCCD1P2,a s
well as the zinc-finger and BTB domain-containing protein
gene ZBTB9, annotated at the very centromeric boundary of
the sequenced region.
The C6orf21 gene (De Vet et al. 2003;X X b a c –
BPG32J3.17-001) of the MHC class III region was
annotated as a separate locus from the adjacent centromeric
locus LY6G6D (splice variants XXbac–BPG32J3.4-001 and
XXbac–BPG32J3.4-002). There was, however, a further
coding splice variant of LY6G6D (XXbac–BPG32J3.4-004),
which spanned not only the other LY6G6D splice variants
but also C6orf21, suggesting that this is a possible so-called
chimeric transcript (Parra et al. 2006).
HLA-DRB1 hypervariable region
Of the five newly annotated MHC haplotypes, APD alone
exhibited the HLA–DRBDR52 antigenic specificity found on
DRB1*3, DRB1*05 (DRB1*11 and DRB1*012) and DR6
(DRB1*13 and DRB1*14) haplotypes and encoded by
HLA–DRB3, whereas the remainder (SSTO, DBB, MANN
and MCF) exhibited the DR53 specificity, encoded by HLA–
DRB4, here annotated for the first time in genomic sequence.
The HLA–DRB53 sequences included three known loci
(HLA–DRB4, HLA–DRB7 and HLA–DRB8), as well as three
novel pseudogenes (DASS–218M11.1, DASS–23B5.1 and
DASS–23B5.2). DASS–23B5.1 corresponds to a pseudogene
derived from the gene for the protein kinase, interferon-
inducible double-stranded RNA dependent activator (Chida
et al. 2001) for which the symbol PRKRAP1 has now been
recognised. A further processed pseudogene, FAM8A5P
(Jamain et al. 2001), was also annotated in the DR53
specificity.
HLA-V and HLA-P
Our analysis showed that the two unprocessed class I
pseudogenes HLA-V and HLA-P ( previously HLA-75 and
HLA-90, Geraghty et al. 1992) should in fact be merged
together; individually they merely represented the 5′ and
3′ portions of a single unprocessed pseudogene, separated
by repeat elements. According to our annotation guidelines
(see “Materials and methods”), the newly merged locus was
assigned the symbol from the 3′ component, in this case,
HLA-P. Best-in-genome nucleotide evidence was found to
support five transcript variants at the 5′ end, which, together
with evidence for continued locus-transcription, led us to
designate the locus as a transcribed pseudogene. Because
transcription appears to still occur at this locus, it was,
therefore, designated as a transcribed pseudogene. A further
six expressed pseudogenes were identified in the MHC
region (HLA–DPB2, HLA-J, CYP21A1P, HLA–DRB6,
HLA–L and PPP1R2P1).
Fig. 1 (continued)
Table 5 Splice-variant statistics for PGF annotation
Type No.
Total splice variants 1,267
Coding 523
Unprocessed_pseudogene 50
Processed_pseudogene 41
Expressed_pseudogene 7
Transcript 271
Putative 71
Retained_intron 263
Nonsense_mediated_decay 30
Artefact 11
Total loci 320
Splice variants annotated in the PGF haplotype
8 Immunogenetics (2008) 60:1–18RCCX hypervariable region
This module within the MHC class III region, named for its
gene content (RP-C4A/B-CYP21-TNXB), may be duplicated
or triplicated (Chung et al. 2002), and the pseudogenes
CYP21A1P, TNXA and STK19P contain the complement
component gene, C4, in either or both of the two versions,
C4A and C4B (Awdeh and Alper 1980). This gene may also
be present in either long (C4AL, C4BL) or short (C4AS,
C4BS) forms depending on the presence or absence of an
inserted HERVC4 element in intron 9. Contrary to our
previous annotation (Stewart et al. 2004) see also legend to
(Fig. 2), the PGF haplotype now appears to possess an
arrangement in which C4AL precedes C4BL, whereas
COX has a single module with C4BS and QBL has a
single module with C4AS (Traherne et al. 2006). For the
new haplotype sequences reported in this paper, SSTO was
bimodular with two copies of C4BL, whereas DBB was
bimodular with C4AL followed by C4BS. Although a
sequence gap was present in MCF, this haplotype appeared
to be bimodular in that, although the telomeric copy of the
C4 gene could not be identified, there was evidence for the
pseudogenes CYP21A1P, TNXA and STK19P in a telomeric
module. The second centromeric module in MCF contained
C4AL. The RCCX region in the APD and MANN
haplotypes was incomplete because of sequence gaps.
C6orf205
Variability in the C6orf205 gene has been reported to
consist of extension of the minisatellite in exon 2 from 27
copies in PGF and COX to 31 copies in QBL (Traherne
et al. 2006). In the newly annotated haplotypes, we found
the minisatellite to extend to 29 in MANN. The APD, DBB
and MCF possessed 27 copies. There was a sequence gap
in this region in the SSTO haplotype.
Table 6 Gene annotation statistics for eight MHC haplotypes
Locus type PGF COX QBL SSTO APD DBB MANN MCF
Coding 165 159 150 131 82 146 129 150
Transcript 28 28 26 26 19 26 27 22
Putative 18 18 15 15 6 16 12 14
Pseudogenes total 98 95 93 98 59 92 95 75
Unprocessed 50 48 48 53 36 52 53 42
Processed 41 42 40 39 19 34 37 28
Expressed 7 5 5 6 4 6 5 5
Artefact 11 11 10 11 0 0 0 0
Total loci 320 311 294 281 166 281 264 261
Total variants 1,267 1,191 1,155 1,058 568 1,138 960 1,115
Annotation statistics for loci in each haplotype. For definitions of locus types see “Materials and methods”
Table 7 Other newly annotated loci
Locus Locus type
XXbac-BCX196D17.5 Transcript
XXbac-BPG116M5.14 Putative
XXbac-BPG116M5.15 Putative
XXbac-BPG116M5.16 Putative
XXbac-BPG118E17.9 Putative
XXbac-BPG126D10.10 Processed pseudogene
XXbac-BPG126D10.11 Processed pseudogene
XXbac-BPG13B8.10 Transcript
XXbac-BPG13B8.9 Unprocessed pseudogene
XXbac-BPG154L12.4 Putative
XXbac-BPG181B23.4 Transcript
XXbac-BPG181M17.4 Putative
XXbac-BPG246D15.8 Transcript
XXbac-BPG248L24.10 Unprocessed pseudogene
XXbac-BPG248L24.9 Processed pseudogene
XXbac-BPG249D20.9 Putative
XXbac-BPG250I8.13 Transcript
XXbac-BPG254F23.5 Putative
XXbac-BPG254F23.6 Putative
XXbac-BPG254F23.7 Transcript
XXbac-BPG254F23.7 Putative
XXbac-BPG27H4.7 Transcript
XXbac-BPG27H4.8 Transcript
XXbac-BPG294E21.7 Processed pseudogene
XXbac-BPG296P20.14 Putative
XXbac-BPG296P20.15 Putative
XXbac-BPG299F13.14 Putative
XXbac-BPG308J9.3 Transcript
XXbac-BPG308K3.5 Putative
XXbac-BPG308K3.6 Transcript
XXbac-BPG309N1.15 Unprocessed pseudogene
XXbac-BPG32J3.18 Putative
XXbac-BPG8G10.2 Unprocessed pseudogene
DAQB-12N14.5 Transcript
DAQB-331I12.5 Putative
DAQB-335A13.8 Transcript
Newly annotated loci without HGNC symbols
Immunogenetics (2008) 60:1–18 9MICA
The known allelic polymorphism of MICA reported for the
DRB1*03 QBL cell line sequence, in which a four-base
insertion (GCGT) extended the open reading frame in
coding exon 5 haplotype (Traherne et al. 2006), was also
present in the DRB1*07 MANN haplotype. The insertion
was absent from PGF, COX and SSTO. No sequence was
available in APD, DBB and MCF for this gene.
PPP1R2P1
The intronless pseudogene PPP1R2P1 reported to have a
full-length open reading frame in the PGF, COX and QBL
haplotypes (Stewart et al. 2004; Traherne et al. 2006) was
found to have a similar open reading frame in the DBB and
MANN haplotypes but to have the frameshift mutation seen
in the original chromosome reference sequence (Mungall
et al. 2003) in the SSTO, APD and MCF haplotypes.
PSORS1C1
The QBL haplotype remains the only one in which there
was a single nucleotide deletion in a polyC tract of exon 5
(Traherne et al. 2006). DBB, MANN and MCF resembled
PGF and COX. No sequence was available for this gene in
SSTO or APD.
POU5F1
The PGF haplotype has been reported to have a disrupted
start codon for alternative splice variant of POU5F1
(Traherne et al. 2006). This disruption was not present in
COX or QBL nor was it present in the further haplotypes
reported in this paper, namely SSTO, DBB, MANN and
MCF. APD had no sequence in this region.
OR2J1
This olfactory receptor OR2J1 has been reported to have
both functional and non-functional alleles (Ehlers et al.
2000), the latter the result of a premature stop codon at
amino acid position 194 introduced by a substitution in the
coding sequence. In our annotation, we found the PGF and
MCF haplotypes to contain the full-coding sequence,
whereas the COX, QBL SSTO, APD, DBB and MANN
haplotypes to contain the truncated sequence as an
unprocessed pseudogene (see above and Fig. 1).
Table 8 Haplotype variation at splice sites
Gene Variant Affected
exons
Donor* Acceptor* dbSNP
cluster ID
Best
evidence
PGF QBL COX SSTO DBB APD MANN MCF
TRIM31 2 3/4 ggt tgg rs28400887 cDNA NC NC NC C ND NC NC C
TRIM31 5 2/3 ggt tgg rs28400887 EST NC NC NC C ND NC NC C
C4B 7 3/4 ggt cgg – EST NC ND NC C NC ND ND ND
C4A 7 3/4 ggt cgg – EST NC NC ND C NC ND ND NC
HLA-DQA1 4 4/5 ggt cgg rs707947 cDNA C C C NC NC ND NC NC
HLA-DQA1 5 4/5 ggt taa/caa rs3667 cDNA NC NC NC C C ND C C
HLA-DRB1 2 2/3 gat cag rs9271083 EST NC C C C C ND C ND
Gene loci and variants that are affected by disruptive variations at splice sites. C Canonical splice site (donor=ngt; acceptor=nag), NC non-
canonical, and ND no data (gene absent or gap). Donor and acceptor variable nucleotides in bold with equivalent dbSNP cluster ID number given
in column to right. The C4A and C4B genes are, for these purposes, effective duplicates of each other. The two TRIM31 variants share the same
splice site (but differ elsewhere in structure). The two HLA–DQA variants share the same donor but have alternative acceptors. Note the mutually
exclusivity of these variants amongst the haplotypes (Hoarau et al. 2004; Hoarau et al. 2005)
Fig. 2 Variation and annotation map of eight MHC haplotypes. The
map represents the complete reference sequence (orange bar split into
three 1.6 Mb sections) labelled PGF and marked with a scale (Mb) and
approximate megabase positions on the NCBI36 build of chromosome
6 (grey milestones). Below the reference sequence are arrows
representing gene positions and orientations colour-coded for variation
status (invariable, black; with synonymous variation only, green; with
non-synonymous, conservative variation, red; with non-synonymous,
non-conservative variation, purple; see Table 8) and their symbols on
a band denoting MHC class (extended class I, green; class I, yellow;
class III, pale orange; class II, light blue; extended class II, pink;
outside MHC, pale grey). Above the reference sequence, coloured
bands represent the sequences of the other seven haplotypes (COX,
orange; QBL, mauve; APD, yellow; DBB, green; MANN, light blue;
SSTO, dark blue; MCF, purple) with sequence gaps in dark grey; the
RCCX hyper-variable region shown with green (C4A block) and/or
red (C4B block) or black (block absent), and the HLA–DRB hyper-
variable region in shades of blue-green. Above each haplotype bar, a
bar-graph represents total variation between the haplotype and the
reference sequence (total variations/10 kb) in dark red. Re-examination
of the sequence AL645922 from the PGF haplotype, which contains the
RCCX region, has shown that the original assembly was erroneous.
Correction of these errors leads us now to the conclusion that the C4A
gene precedes the C4B gene in this clone sequence. This new gene
order is reflected in Fig. 2
b
10 Immunogenetics (2008) 60:1–18TRIM27
C6orf100
ZNF311
OR2W1
OR2B3
OR2J1
OR2J3
OR2J2
OR5U1
OR5V1
OR12D3
OR12D2
OR11A1
OR10C1
OR2H1
MAS1L
UBD
OR2H2
GABBR1
MOG
ZFP57
HLA-F
HLA-G
HLA-A
ZNRD1
PPP1R11
RNF39
TRIM31
TRIM40
TRIM10
TRIM15
TRIM26
TRIM39
RPP21
HLA-E
GNL1
PRR3
ABCF1
PPP1R10
MRPS18B
C6orf134
C6orf136
DHX16
KIAA1949
NRM
MDC1
TUBB
FLOT1
IER3
DDR1
GTF2H4
VARS2
SFTPG
DPCR1
C6orf205
C6orf15
PSORS1C1
CDSN
PSORS1C2
CCHCR1
TCF19
POU5F1
HLA-C
HLA-B
MICA
MICB
MCCD1
BAT1
ATP6V1G2
NFKBIL1
LTA
TNF
LTB
LST1
NCR3
AIF1
BAT2
BAT3
APOM
C6orf47
BAT4
CSNK2B
LY6G5B
LY6G5C
BAT5
C6orf21
LY6G6E
LY6G6D
LY6G6C
C6orf25
DDAH2
CLIC1
MSH5
C6orf26
C6orf27
VARS
LSM2
HSPA1L
HSPA1A
HSPA1B
C6orf48
NEU1
SLC44A4
EHMT2
ZBTB12
C2
CFB
RDBP
SKIV2L
DOM3Z
STK19
C4A
C4B
CYP21A2
TNXB
CREBL1
FKBPL
PRRT1
PPT2
EGFL8
AGPAT1
RNF5
AGER
PBX2
GPSM3
NOTCH4
C6orf10
BTNL2
HLA-DRA
HLA-DRB5
HLA-DRB1
HLA-DQA1
HLA-DQB1
HLA-DQA2
HLA-DQB2
HLA-DOB
TAP2
PSMB8
TAP1
PSMB9
HLA-DMB
HLA-DMA
BRD2
HLA-DOA
HLA-DPA1
HLA-DPB1
HLA-DPB2
COL11A2
RXRB
SLC39A7
HSD17B8
RING1
VPS52
RPS18
B3GALT4
WDR46
PFDN6
RGL2
TAPBP
ZBTB22
DAXX
KIFC1
PHF1
CUTA
SYNGAP1
ZBTB9
C
O
X
Q
B
L
A
P
D
D
B
B
M
A
N
N
S
S
T
O
M
C
F
C
O
X
Q
B
L
A
P
D
D
B
B
M
A
N
N
S
S
T
O
M
C
F
C
O
X
Q
B
L
A
P
D
D
B
B
M
A
N
N
S
S
T
O
M
C
F
P
G
F
P
G
F
P
G
F
0
.
0
0
.
1
0
.
2
0
.
3
0
.
4
0
.
5
0
.
6
0
.
7
0
.
8
0
.
9
1
.
0
1
.
1
1
.
2
1
.
3
1
.
4
1
.
5
1
.
6
1
.
7
1
.
8
1
.
9
2
.
0
2
.
1
2
.
2
2
.
3
2
.
4
2
.
5
2
.
6
2
.
7
2
.
8
2
.
9
3
.
0
3
.
1
3
.
2
3
.
3
3
.
4
3
.
5
3
.
6
3
.
7
3
.
8
3
.
9
4
.
0
4
.
1
4
.
2
4
.
3
4
.
4
4
.
5
4
.
6
4
.
7
1
.
6
M
b
3
.
2
M
b
4
.
8
M
b
2
9
3
0
3
1
3
2
3
3
C
4
A
C
4
B
D
R
B
t
e
l
o
m
e
r
i
c
c
e
n
t
r
o
m
e
r
i
c
Immunogenetics (2008) 60:1–18 11Other annotation differences
Other loci included in the current but not the previous PGF
annotation were HCG4P11, HCG4P8, HCG4P7, HCG4P5,
HCG4P3 and the loci without symbols listed in Table 7.
Previously annotated loci not annotated in this study or
considered artefacts because they did not reach our current
standards of annotation included HLA-X, C6orf215,
HCG2P7, HCG8, HCP5P2, HCP5P3, HCP5P6,
HCP5P12, HCP5P13, HCP5P14, HCP5P15, HCG8 and
HCG26.
Non-canonical splice sites
Eight variants within six loci were shown to exhibit
haplotypic variation at their splice sites (canonical to non-
canonical motif; Table 8). These variations may affect the
gene expression at the post-transcriptional level. Hoarau
et al. (2004, 2005) have already described the differential
splicing within the HLA–DQA1 locus, and this can clearly
be seen by comparing the new HLA–DQA1 annotation
through the VEGA genome browser.
Table 9 Variation status of the main coding variant of each gene in
the PGF haplotype annotation
Invariable Synonymous
variation only
Non-synonymous variation
Conservative
variation
Non-
conservative
variation
ABCF1 BAT1
a AGER BAT2
AGPAT1 BAT5 BRD2
a BAT3
AIF1 C2 BTNL2 BAT4
APOM CREBL1 C6orf21 C4A
ATP6V1G2 DAXX C6orf27 C4B
B3GALT4 DDR1
a CFB C6orf10
C6orf134 GNL1 DOM3Z C6orf100
C6orf136
a GPSM3 DPCR1 C6orf15
C6orf26 GTF2H4 EGFL8 C6orf205
C6orf48 HLA-DOA
a EHMT2 C6orf25
CLIC1 HSPA1B FKBPL C6orf47
CSNK2B LY6G6C GABBR1 CCHCR1
CUTA MSH5 HLA-DMA CDSN
CYP21A2 PBX2 HLA-DOB COL11A2
DDAH2 POU5F1 HLA-DQB2 DHX16
FLOT1 PPP1R11 HLA-DRA HLA-A
HLA-DPA1 PRR3 HSPA1A HLA-B
HLA-DRB5 RING1 LY6G6D HLA-C
HSD17B8 RNF5 MCCD1 HLA-DMB
KIFC1
a RXRB MOG
a HLA-DPB1
LSM2 SYNGAP1 OR11A1 HLA-DPB2
LST1 TRIM10 OR2H2 HLA-DQA1
LTB TRIM26 OR2J1 HLA-DQA2
LY6G5C TRIM27 OR2J2 HLA-DQB1
LY6G6E TRIM39
a OR2J3 HLA-DRB1
MAS1L VPS52 PHF1 HLA-E
MRPS18B ZBTB12 PSMB9 HLA-F
NCR3 ZBTB9 RPP21 HLA-G
NEU1 ZNRD1 SFTPG HSPA1L
NRM SKIV2L IER3
OR2B3 SLC44A4 KIAA1949
OR2H1 TAP2 LTA
OR2W1 TRIM15 LY6G5B
PFDN6 WDR46 MDC1
PPP1R10 ZBTB22 MICA
PRRT1 ZNF311 MICB
PSMB8
b NFKBIL1
RDBP NOTCH4
RGL2 OR10C1
RPS18 OR12D2
SLC39A7 OR12D3
STK19 OR5U1
TNF OR5V1
TUBB PPT2
ZFP57 PSORS1C1
PSORS1C2
RNF39
TAP1
TAPBP
TCF19
TNXB
Table 9 (continued)
Invariable Synonymous
variation only
Non-synonymous variation
Conservative
variation
Non-
conservative
variation
TRIM31
TRIM40
UBD
VARS
VARSL
Gene coding sequences may be invariable (no recorded variation),
have synonymous variation only (variation at the nucleotide but not
the peptide level) or have non-synonymous variation (variation at both
the nucleotide and peptide level), which in turn, may be conservative
or non-conservative variation according to the criteria of positive or
negative values in the BLOSUM62 matrix. The main coding variant is
that numbered 001 in the VEGA database except for LY6G6E and
HLA-DPB2 where the main variant is not coding. C4A and C4B were
excluded from calculation of variation because the order of these
genes in the PGF sequence precluded alignment with other haplotype
sequences. Nevertheless, alignment of the coding sequences for each
gene separately showed that there were non-synonymous, non-
conservative variations. HLA-DRB5 is present in this study only in
the PGF haplotype and, therefore, here appears invariable
aCoding genes where the main variant does not harbour non-
conservative, non-synonymous variation but other variants do (BAT1
BRD2 DDR1 C6orf136 HLA-DOA MOG KIFC1 and TRIM39)
bSimilarly, coding genes where the main variant does not harbour
conservative non-synonymous variation but other variants do (PSMB8)
12 Immunogenetics (2008) 60:1–18Table 10 Major indels in the form of retrotransposible elements
Chr6
pos’n
Flanking loci Presence in haplotype Details
PGF COX QBL SSTO APD DBB MANN MCF
29002370 TRIM27:C6orf100 C C C C ? ? C C Complex region (A)
29440424 OR5V1:OR12D3 ✓✓ ? ✓ ? ? X X AluYa5
29784097 C6orf40:HCP5P15 ✓ X ✓✓ ? X X X AluYa5/8 175..304
29788451 Within HCP5P15 X X ✓ X?✓✓ X AluYa5/8 176..310
29794763 HCP5P15:HLA-F ✓ XX✓ ? X X X SVA_E plus simple rpt.s
29922942 HLA-G:MICF ✓ X ✓✓ ✓✓✓ ✓L1ME3B 5940..6165
29954495 MICF:HLA-H ✓ X X X X X X X HERVK9 inserted in MER9
30008633 HLA-K:HLA-21 ✓ XX✓ XX✓ ? SVA E/F plus simple rpt.
30106475 HCG8:ETF1P1 X ✓ XX ✓✓X X AluYb8
30547387 SUCLA2P:RANP1 X X X ✓ ? X X ? AluJb 1..283 and parts
of MLT1D/L1PBa
31079582 C6orf205:HCG22 X X ✓ X X X ? X AluYb8 37..297
31117638 C6orf205:HCG22 ✓ XX✓✓ X ✓✓ AluY (whole & part)
and MER63 1017..1062
31301931 HCG27:HLA-C ✓✓ X ✓ ? ✓✓ ✓HERV3 part (6489...7339)
31320352 HCG27:HLA-C ✓ X X X ? X X X SVA_F 349..850 plus
GC rich rpt.
31358220 RPL3P2:WASF5P X X ✓ X ? X X X AluY 35..306
31400900 WASF5P:HLA-B ✓✓ ✓✓ ? X X X AluSp plus L1PREC2
part (3205...4617)
31405648 WASF5P:HLA-B ✓ X ✓✓ ? X x x HERVIP10F (part) and
AluSg (only cf CX DB)
31418854 WASF5P:HLA-B ✓✓ ✓✓ ? ✓✓ X L1PA5 part (5503..5876)
31530995 MICA:HCP5 ✓ X?✓ ? ? X ? SVA B/F plus simple rpt.s
32421915 within C6orf10 ✓ XX✓ XX✓ X AluYb8
32486228 BTNL2:HLA-DRA ✓✓ ✓✓ ✓X X X L1P1/L1HS parts
32655545 HLA-DRB1 intron 5 ✓ xxX?✓✓ ? AluYa5 within more
or less partial LTR12
32660731 HLA-DRB1 intron 1 X/X ✓/X X/X ✓/✓ ? ✓/✓✓ /✓ ? Tigger4/AluSx
32661119 HLA-DRB1 intron 1 C C C C ? C C ? Complex region (B)
32663167 HLA-DRB1 intron 1 X/✓✓ /✓✓ /✓✓ /X ? ✓/X ✓/X ? AluSq/AluY
32669534 HLA-DRB1:HLA-DQA1 C C C C ? C C ? Complex region (C)
32679461 HLA-DRB1:HLA-DQA1 ✓ X X X ? X X ? AluY
32693271 HLA-DRB1:HLA-DQA1 ✓✓ ✓✓ ?X ✓ ? L1PA4 (parts)
32697545 HLA-DRB1:HLA-DQA1 X X X X ? ✓✓ ? L1HS 7..6032
32701428 HLA-DRB1:HLA-DQA1 ✓ X ✓✓ ? x X x L1PA2 part and from
CX: MER2B and AluY
32728179 HLA-DQA1: HLA-DQB1 C C C C ? C C C Complex region (D)
32739664 within HLA-DQB1 X X ✓ X?X ✓ X AluY
32743646 HLA-DQB1: MTCO3P1 X X X X ? ✓ X X LTR13
32746780 HLA-DQB1: MTCO3P1 X X X X ? ✓ X ✓ L1PA4 (parts)
32751442 HLA-DQB1: MTCO3P1 X X X X ? X ✓ X LTR5_Hs
32753489 HLA-DQB1: MTCO3P1 ✓✓ ✓✓ ?X ✓ X L1PA10 268..4888
around L1PA4 (part)
32756020 HLA-DQB1: MTCO3P1 X X X X ? X ✓ X LTR5_Hs
32764047 HLA-DQB1: MTCO3P1 ✓✓ ✓✓ ?X ✓ X AluSx
32765930 HLA-DQB1: MTCO3P1 X X X X ? X ✓ X AluYa5
32785062 MTCO3P1:HLA-DQB3 ✓✓ ✓✓ ? X X X Tigger4 (Zombi)/L1HS
(parts) and T-rich
32795150 MTCO3P1:HLA-DQB3 X X X X X ✓ X ✓ AluY
32796573 MTCO3P1:HLA-DQB3 X X X X X ✓ X ✓ AluY
32815974 HLA-DQB3: HLA-DQA2 X ✓ XX ✓ X X X AluYa5
32857369 HLA-DQB2:HLA-DOB ✓ X ✓✓ XX✓ X AluYg6
32881426 HLA-DQB2:HLA-DOB X X ? ✓✓ X X ? AluYa5
Immunogenetics (2008) 60:1–18 13Combination of variation and annotation data
The data for sequence contig length, gaps, variation rate
within haplotypes and PGF coding gene annotation have
been combined in the map in Fig. 2. This illustrates the
concentration of variation around the HLA gene loci,
specifically in 3 areas: around HLA-F, HLA-G and HLA-
A; around HLA-C and HLA-B; and around HLA-DRB1,
HLA-DQA1, HAL-DQB1, HLA-DQA2 and HLA-DQB2.
The variation status of genes of the PGF haplotype is
shown in Table 9.
As well as the variations reported above, major indels
revealed as breaks in cross_match discrepancy lists and
analysed by RepeatMasker are given in Table 10. Many of
these have been previously reported (Dangel et al. 1994;
Dunn et al. 2003; Dunn et al. 2002; Gaudieri et al. 1999;
Horton et al. 1998; Kulski and Dunn 2005; Stewart et al.
2004). These indels were most frequently but not exclusively
associated with AluY elements.
Four of these major indels were complex and designated
as complex regions A, B, C and D in Table 10. They
include three known regions from the comparison of the
PGF and COX haplotypes (Stewart et al. 2004). Complex
region A (involving MIR, MER41B, MER115, AluSx,
Flam_C, AluSg, AluY, AluSx, L2 and MER38 elements)
maps between TRIM27 and C6orf100 and was found to be
deleted in COX but present in PGF, QBL, SSTO, MANN
and MCF. Complex region B (involving L2 and AluY
elements) maps to intron 1 of HLA–DRB1 and was also
found by comparing PGF with COX, QBL, DBB, MANN
and SSTO. Complex region C (SVA and low-complexity
repeat elements) maps between HLA–DRB1 and HLA–
DQA1 and was noted in COX as a deletion of the SVA and
low-complexity repeats. Whereas, DBB, MANN and SSTO
displayed the same deletion, as well as a telomeric deletion
of AluSx/MIRb, QBL had both deletions plus that of an
intervening 2.5 kb sequence containing Alu,L 3a n d
MLT1A1 elements. Complex region D maps between
HLA−DQA1 and HLA−DQB1 and is more complicated
than previously reported. At the telomeric end, PGF lacks
an L1PA4 fragment of >300 bp that is present in COX,
QBL, SSTO and MCF and is also absent in DBB and
MANN where it is interrupted by about 1.3 kb of SVA
sequence. Centromeric to this PGF contains an AluSx,a n
AluY and an AluYd2, flanked by long interspersed nuclear
element repeats, all deleted in the other haplotypes. Further
towards the centromere there is an L1MA7 fragment, into
which in PGF alone there are insertions of an AluSx
followed by an AluY; a subsequent AluSg present in all
haplotypes contains an insertion of 795 bp of SVA
sequence in just COX and QBL. Finally, at the centromeric
end of this region, PGF uniquely contains intact MER11C
and LTR5 elements.
Representation of haplotypes within European populations
The eight haplotypes analysed in this study were selected
on the basis of their association with type 1 diabetes and
multiple sclerosis and their high population frequencies. To
determine how representative these haplotypes are with
respect to SNP haplotypic diversity in a population, we
determined their distribution in the haplotypic tree space in
the European population.
For this analysis, we selected a segment of ~214 kb,
spanning the HLA–DRB1 and HLA–DQB1 genes in a
population of European ancestry with known HLA allelic
data (de Bakker et al. 2006). Phylogenetic analysis of 180
founder haplotypes derived from genotypic data (54
substitutions) shows that the eight haplotypes selected as
part of the MHC Haplotype Project share identical HLA
alleles over most of the tree space (Fig. 3a), representing
almost the entire variation observed in the population
Table 10 (continued)
Chr6
pos’n
Flanking loci Presence in haplotype Details
PGF COX QBL SSTO APD DBB MANN MCF
32887265 HLA-DQB2:HLA-DOB ✓ X?X XX✓✓ LTR42 and parts of
L1MC5 and AluSc
3..105
33201559 within HLA-DPB2 ✓ XXX ✓ ? X ? AluYb8
33234360 HCG24:COL11A2 ✓✓ ✓?? ✓✓ X AluY (1..293)
AluJb (26..306)
Where there was a break in the cross_match discrepancy list match between two clones, the inserted sequence was extracted and subjected to
analysis by RepeatMasker to assess the number of major indels that were a result of retrotransposible elements. Chromosome 6 position (NCBI35/
36) of the inserted sequence was that of the midpoint where the sequence was an insertion in PGF or the position before the deletion in PGF.
Flanking loci were retrieved from the annotation. Insertion in a haplotypes is indicated by ‘✓’, deletion by ‘X’, complex regions by ‘C’. Where
there is a sequence gap in a haplotype corresponding to the indel, this is shown by ‘?’. Four complex deletion/insertion events are listed: A, B, C
and D; for details, see text
14 Immunogenetics (2008) 60:1–18assayed with the exception of two branches (DRB1*1103–
DQB1*0301 and DRB1*0101–DQB1*0501).
Haplotype diversity in this sub-population is restricted to
relatively few haplotype clusters (Fig. 3b). Each cluster
consists of a founder haplotype, depicted by the most
frequent and centrally located haplotype within the cluster.
Recently derived haplotypes show lower frequencies and
are connected to the central haplotype by relatively few
mutation steps (in this case, up to three). This phylogenetic
network clearly shows that all the sequenced haplotypes
occupy central positions in their respective haplotypic
groups. Inferences about phylogenetic relationships between
haplotype clusters are, however, only approximate as a
consequence of recombination events.
Fig. 3 Clusters of haplotypes in the European haplotypic diversity.
Phylogenetic relationship of 180 founder SNP haplotypes from CEPH
triosspanninga214-kbsegmentoftheMHCclassIIregion,includingthe
HLA-DRB1a n dHLA-DQB1 genes (54 substitutions from rs2187823 to
rs2856691). a Sequenced haplotypes are widely distributed in this NJ
tree and represent the vast majority of the variation in the population
sampled. Four-digit alleles are indicated for the corresponding DRB1
and DQB1 genes in each haplotype ID label to highlight the HLA
haplotypic distribution based on the underlying nucleotide variation.
T h eN Jt r e ew a sc o n s t r u c t e du s i ng pairwise genetic distances
considering the Kimura 2-parameters model without correction for rate
variation among sites as implemented in the MEGA2 software (Kumar
et al. 2001). b Each haplotype sequenced is associated to a single
haplotype cluster. This phylogenetic network (Bandelt et al. 1999) also
shows that clusters (shaded area) are constituted by one central
haplotype and its derivatives. Circles represent individual haplotypes,
and the size of the circle is proportional to the haplotype frequency. The
length of the lines connecting nodes is relative to the distance between
them, e.g. distances within shaded areas (clusters) never exceed three
mutation steps. Cluster of haplotypes sharing HLA alleles with
sequenced cell lines are named accordingly: COX and QBL:
DRB1*0301 DQB1*0201–PGF: DRB1*1501 DQB1*0602–APD:
DRB1*1301 DQB1*0603–MCF: DRB1*0401 DQB1*0301–DBB:
DRB1*0701 DQB1*0303–SSTO: DRB1*0403 DQB1*0302–MANN:
DRB1*0701 DQB1*0202. HLA haplotypes DRB1*1103–DQB1*0301
and DRB1*0101–DQB1*0501 indicate the two major haplotype
clusters not represented in the MHC haplotype project data
Immunogenetics (2008) 60:1–18 15It should also be noted that SNP haploptypes derived
from CEPH pedigrees of European ancestry by no means
represent an exhaustive sampling of European diversity.
Nevertheless, the sampling has been shown to represent the
European population in the UK reasonably well (Ke et al.
2005). In conclusion, our analysis demonstrates that the
HLA haplotypes selected for the MHC Haplotype Project
are ancestral haplotypes, representative of MHC diversity in
the European population.
Conclusion and outlook
The MHC Haplotype Project has succeeded in providing a
new public resource for immune-linked disease and
population genetic studies. First reports from studies using
the resource indicate that it adds significant power to the
identification and fine-mapping of disease-associated var-
iations (Yeo et al. 2007). The data have also contributed to
the recent identification of a first set of HLA tag SNPs,
which hold great promise for future applications in clinical
settings, e.g. to complement or replace classical HLA-
typing in transplant medicine (de Bakker et al. 2006).
While costs and other limitations of the current (capillary)
sequencing technology have restricted our study to only
few (eight) MHC haplotypes, the number of new variations
found, combined with the fact that no variation plateau has
yet been reached, indicates that there are many more
variations to be discovered. The recent introduction of
several new and massively parallel sequencing platforms
(for review, see Bentley 2006) has created the opportunity
to do just that by re-sequencing haplotypes and, eventually,
entire genomes at the population level and as integral part
of case control studies. Because of its wide-ranging medical
importance, the MHC can be expected to be among the first
regions of the human genome to be sequenced in this way.
Such sequencing will provide the critical, and until now
missing, data to identify causal variations and their
underlying mechanisms on an unprecedented scale.
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